Sign in

CIK 0000711377

  • Large accelerated filer

NEOGEN CORP

Sign in to watch
Ticker
NEOG
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
May 31
Incorporated
MI
Entity type
Operating
EIN
382367843
Phone
+1 517-372-9200
Business address
620 LESHER PLACE, LANSING, MI, 48912
Open-market buys, last 90 days
$6,035
in 1 filing
Open-market sales, last 90 days
$114,676
in 1 filing

Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Yarwood Jeremy −$115K Chief Scientific Officer sold 100% of stake
  2. Nassif Mikheal +$6K CEO 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-10-28 Rocklin Amy M Chief Legal Officer Exercise or conversion · Restricted Stock Units −9,475 $13.81 $131K 18,950
2024-10-28 Naemura David H. Chief Financial Officer Exercise or conversion +15,504 $13.81 $214K 45,544
2024-10-28 Naemura David H. Chief Financial Officer Shares withheld for taxes −6,450 $13.81 $89K 39,094
2024-10-28 Naemura David H. Chief Financial Officer Exercise or conversion · Restricted Stock Units −15,504 $13.81 $214K 31,008
2024-10-28 Jones Douglas Edward Chief Operating Officer Exercise or conversion +15,504 $13.81 $214K 75,671
2024-10-28 Jones Douglas Edward Chief Operating Officer Shares withheld for taxes −4,512 $13.81 $62K 71,159
2024-10-28 Jones Douglas Edward Chief Operating Officer Exercise or conversion · Restricted Stock Units −15,504 $13.81 $214K 31,008
2024-10-28 ADENT JOHN EDWARD CEO Exercise or conversion +38,760 $13.81 $535K 257,409
2024-10-28 ADENT JOHN EDWARD CEO Shares withheld for taxes −11,280 $13.81 $156K 246,129
2024-10-28 ADENT JOHN EDWARD CEO Exercise or conversion · Restricted Stock Units −38,760 $13.81 $535K 77,520
2024-10-24 Woteki Catherine E Director Grant or award +6,075 $13.58 $82K 17,397
2024-10-24 Woteki Catherine E Director Grant or award · Common Stock (Right to Buy) +18,653 18,653
2024-10-24 Tobin James P Director Grant or award +6,075 $13.58 $82K 37,397
2024-10-24 Tobin James P Director Grant or award · Common Stock (Right to Buy) +18,653 18,653
2024-10-24 RODRIGUEZ RAFAEL A Director Grant or award +6,075 $13.58 $82K 17,397
2024-10-24 RODRIGUEZ RAFAEL A Director Grant or award · Common Stock (Right to Buy) +18,653 18,653
2024-10-24 Green Ronald D Director Grant or award +6,075 $13.58 $82K 22,704
2024-10-24 Green Ronald D Director Grant or award · Common Stock (Right to Buy) +18,653 18,653
2024-10-24 Gupta Aashima Director Grant or award +6,075 $13.58 $82K 15,840
2024-10-24 Gupta Aashima Director Grant or award · Common Stock (Right to Buy) +18,653 18,653

Page 13 of 21 · 414 trades